nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CBR1—Doxorubicin—kidney cancer	0.476	0.641	CbGbCtD
Tetrabenazine—CYP2D6—Temsirolimus—kidney cancer	0.0991	0.133	CbGbCtD
Tetrabenazine—CYP2D6—Pazopanib—kidney cancer	0.0521	0.0701	CbGbCtD
Tetrabenazine—CYP2D6—Erlotinib—kidney cancer	0.0372	0.05	CbGbCtD
Tetrabenazine—CYP2D6—Sorafenib—kidney cancer	0.0302	0.0407	CbGbCtD
Tetrabenazine—CYP2D6—Vinblastine—kidney cancer	0.0298	0.0402	CbGbCtD
Tetrabenazine—CYP2D6—Doxorubicin—kidney cancer	0.0183	0.0247	CbGbCtD
Tetrabenazine—Donepezil—ACHE—kidney cancer	0.0072	1	CrCbGaD
Tetrabenazine—CBR1—Vincristine—Vinblastine—kidney cancer	0.00412	0.679	CbGdCrCtD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—kidney cancer	0.00382	0.124	CbGpPWpGaD
Tetrabenazine—CBR1—Azacitidine—Gemcitabine—kidney cancer	0.00194	0.32	CbGdCrCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—ALDH1A1—kidney cancer	0.00175	0.0568	CbGpPWpGaD
Tetrabenazine—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—kidney cancer	0.00146	0.0474	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—PTGS1—kidney cancer	0.00138	0.0446	CbGpPWpGaD
Tetrabenazine—CYP2D6—urine—kidney cancer	0.0011	0.156	CbGeAlD
Tetrabenazine—CBR1—nephron tubule—kidney cancer	0.00103	0.146	CbGeAlD
Tetrabenazine—CBR1—NRF2 pathway—SLC5A3—kidney cancer	0.00102	0.033	CbGpPWpGaD
Tetrabenazine—CBR1—renal system—kidney cancer	0.000934	0.133	CbGeAlD
Tetrabenazine—CBR1—kidney—kidney cancer	0.000903	0.128	CbGeAlD
Tetrabenazine—CBR1—NRF2 pathway—KEAP1—kidney cancer	0.00089	0.0288	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—CYP1A1—kidney cancer	0.000889	0.0288	CbGpPWpGaD
Tetrabenazine—CBR1—cortex of kidney—kidney cancer	0.000879	0.125	CbGeAlD
Tetrabenazine—CBR1—gonad—kidney cancer	0.000837	0.119	CbGeAlD
Tetrabenazine—CBR1—cardiac atrium—kidney cancer	0.000836	0.119	CbGeAlD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.00081	0.0262	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000658	0.0213	CbGpPWpGaD
Tetrabenazine—Dysuria—Paclitaxel—kidney cancer	0.000549	0.00266	CcSEcCtD
Tetrabenazine—Diarrhoea—Temsirolimus—kidney cancer	0.000547	0.00265	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Paclitaxel—kidney cancer	0.000546	0.00265	CcSEcCtD
Tetrabenazine—Leukopenia—Sunitinib—kidney cancer	0.000545	0.00264	CcSEcCtD
Tetrabenazine—CYP2D6—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000544	0.0176	CbGpPWpGaD
Tetrabenazine—Asthenia—Pazopanib—kidney cancer	0.000541	0.00262	CcSEcCtD
Tetrabenazine—Insomnia—Everolimus—kidney cancer	0.000538	0.00261	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SLC5A5—kidney cancer	0.000537	0.0174	CbGpPWpGaD
Tetrabenazine—Angiopathy—Vincristine—kidney cancer	0.000537	0.0026	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—kidney cancer	0.000535	0.00259	CcSEcCtD
Tetrabenazine—Irritability—Capecitabine—kidney cancer	0.000532	0.00258	CcSEcCtD
Tetrabenazine—Dyspnoea—Everolimus—kidney cancer	0.00053	0.00257	CcSEcCtD
Tetrabenazine—Somnolence—Everolimus—kidney cancer	0.000529	0.00256	CcSEcCtD
Tetrabenazine—Dizziness—Temsirolimus—kidney cancer	0.000529	0.00256	CcSEcCtD
Tetrabenazine—CBR1—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000528	0.0171	CbGpPWpGaD
Tetrabenazine—Dry mouth—Sorafenib—kidney cancer	0.000527	0.00255	CcSEcCtD
Tetrabenazine—Ataxia—Capecitabine—kidney cancer	0.000524	0.00254	CcSEcCtD
Tetrabenazine—Dysarthria—Doxorubicin—kidney cancer	0.000523	0.00254	CcSEcCtD
Tetrabenazine—Depression—Paclitaxel—kidney cancer	0.000522	0.00253	CcSEcCtD
Tetrabenazine—Cardiac disorder—Gemcitabine—kidney cancer	0.000521	0.00253	CcSEcCtD
Tetrabenazine—Insomnia—Erlotinib—kidney cancer	0.000519	0.00252	CcSEcCtD
Tetrabenazine—Decreased appetite—Vinblastine—kidney cancer	0.000519	0.00252	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SLC2A1—kidney cancer	0.000519	0.0168	CbGpPWpGaD
Tetrabenazine—Mental disorder—Vincristine—kidney cancer	0.000518	0.00251	CcSEcCtD
Tetrabenazine—Decreased appetite—Everolimus—kidney cancer	0.000517	0.00251	CcSEcCtD
Tetrabenazine—Leukopenia—Dactinomycin—kidney cancer	0.000516	0.0025	CcSEcCtD
Tetrabenazine—Diarrhoea—Pazopanib—kidney cancer	0.000516	0.0025	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.000515	0.0025	CcSEcCtD
Tetrabenazine—Fatigue—Everolimus—kidney cancer	0.000513	0.00249	CcSEcCtD
Tetrabenazine—Dyspnoea—Erlotinib—kidney cancer	0.000512	0.00248	CcSEcCtD
Tetrabenazine—Constipation—Vinblastine—kidney cancer	0.000511	0.00248	CcSEcCtD
Tetrabenazine—Angiopathy—Gemcitabine—kidney cancer	0.000509	0.00247	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Capecitabine—kidney cancer	0.000509	0.00247	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Capecitabine—kidney cancer	0.000509	0.00247	CcSEcCtD
Tetrabenazine—Constipation—Everolimus—kidney cancer	0.000509	0.00247	CcSEcCtD
Tetrabenazine—Vomiting—Temsirolimus—kidney cancer	0.000509	0.00247	CcSEcCtD
Tetrabenazine—Gait disturbance—Doxorubicin—kidney cancer	0.000507	0.00246	CcSEcCtD
Tetrabenazine—Dry mouth—Sunitinib—kidney cancer	0.000507	0.00246	CcSEcCtD
Tetrabenazine—Nervous system disorder—Sorafenib—kidney cancer	0.000507	0.00246	CcSEcCtD
Tetrabenazine—Breast disorder—Capecitabine—kidney cancer	0.000504	0.00244	CcSEcCtD
Tetrabenazine—Skin disorder—Sorafenib—kidney cancer	0.000502	0.00243	CcSEcCtD
Tetrabenazine—Headache—Temsirolimus—kidney cancer	0.000501	0.00243	CcSEcCtD
Tetrabenazine—Decreased appetite—Erlotinib—kidney cancer	0.000499	0.00242	CcSEcCtD
Tetrabenazine—Dizziness—Pazopanib—kidney cancer	0.000498	0.00242	CcSEcCtD
Tetrabenazine—Fatigue—Erlotinib—kidney cancer	0.000495	0.0024	CcSEcCtD
Tetrabenazine—Feeling abnormal—Vinblastine—kidney cancer	0.000492	0.00239	CcSEcCtD
Tetrabenazine—Constipation—Erlotinib—kidney cancer	0.000491	0.00238	CcSEcCtD
Tetrabenazine—Feeling abnormal—Everolimus—kidney cancer	0.00049	0.00238	CcSEcCtD
Tetrabenazine—Nervous system disorder—Sunitinib—kidney cancer	0.000487	0.00236	CcSEcCtD
Tetrabenazine—Skin disorder—Sunitinib—kidney cancer	0.000483	0.00234	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—EGR1—kidney cancer	0.000482	0.0156	CbGpPWpGaD
Tetrabenazine—Dysphagia—Capecitabine—kidney cancer	0.000482	0.00234	CcSEcCtD
Tetrabenazine—Vomiting—Pazopanib—kidney cancer	0.000479	0.00232	CcSEcCtD
Tetrabenazine—Bradycardia—Paclitaxel—kidney cancer	0.000478	0.00232	CcSEcCtD
Tetrabenazine—Nausea—Temsirolimus—kidney cancer	0.000475	0.0023	CcSEcCtD
Tetrabenazine—Agitation—Vincristine—kidney cancer	0.000473	0.00229	CcSEcCtD
Tetrabenazine—Headache—Pazopanib—kidney cancer	0.000472	0.00229	CcSEcCtD
Tetrabenazine—Body temperature increased—Everolimus—kidney cancer	0.00047	0.00228	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Paclitaxel—kidney cancer	0.000464	0.00225	CcSEcCtD
Tetrabenazine—Bronchitis—Capecitabine—kidney cancer	0.000463	0.00225	CcSEcCtD
Tetrabenazine—Leukopenia—Vincristine—kidney cancer	0.000461	0.00224	CcSEcCtD
Tetrabenazine—Urethral disorder—Paclitaxel—kidney cancer	0.000461	0.00223	CcSEcCtD
Tetrabenazine—Dyspnoea—Sorafenib—kidney cancer	0.00046	0.00223	CcSEcCtD
Tetrabenazine—Body temperature increased—Erlotinib—kidney cancer	0.000454	0.0022	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000453	0.0147	CbGpPWpGaD
Tetrabenazine—Dysuria—Capecitabine—kidney cancer	0.000451	0.00218	CcSEcCtD
Tetrabenazine—Insomnia—Sunitinib—kidney cancer	0.00045	0.00218	CcSEcCtD
Tetrabenazine—Decreased appetite—Sorafenib—kidney cancer	0.000449	0.00218	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Capecitabine—kidney cancer	0.000448	0.00217	CcSEcCtD
Tetrabenazine—Nausea—Pazopanib—kidney cancer	0.000448	0.00217	CcSEcCtD
Tetrabenazine—Ecchymosis—Doxorubicin—kidney cancer	0.000448	0.00217	CcSEcCtD
Tetrabenazine—Fatigue—Sorafenib—kidney cancer	0.000445	0.00216	CcSEcCtD
Tetrabenazine—Dyspnoea—Sunitinib—kidney cancer	0.000443	0.00215	CcSEcCtD
Tetrabenazine—Constipation—Sorafenib—kidney cancer	0.000442	0.00214	CcSEcCtD
Tetrabenazine—Eye disorder—Paclitaxel—kidney cancer	0.000439	0.00213	CcSEcCtD
Tetrabenazine—Leukopenia—Gemcitabine—kidney cancer	0.000437	0.00212	CcSEcCtD
Tetrabenazine—Cardiac disorder—Paclitaxel—kidney cancer	0.000436	0.00211	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GSTP1—kidney cancer	0.000433	0.014	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Sunitinib—kidney cancer	0.000432	0.00209	CcSEcCtD
Tetrabenazine—Asthenia—Vinblastine—kidney cancer	0.000429	0.00208	CcSEcCtD
Tetrabenazine—Fatigue—Sunitinib—kidney cancer	0.000428	0.00208	CcSEcCtD
Tetrabenazine—Depression—Capecitabine—kidney cancer	0.000428	0.00208	CcSEcCtD
Tetrabenazine—Asthenia—Everolimus—kidney cancer	0.000427	0.00207	CcSEcCtD
Tetrabenazine—Angiopathy—Paclitaxel—kidney cancer	0.000426	0.00207	CcSEcCtD
Tetrabenazine—Constipation—Sunitinib—kidney cancer	0.000425	0.00206	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000413	0.002	CcSEcCtD
Tetrabenazine—Nervous system disorder—Vincristine—kidney cancer	0.000412	0.002	CcSEcCtD
Tetrabenazine—Asthenia—Erlotinib—kidney cancer	0.000412	0.002	CcSEcCtD
Tetrabenazine—Mental disorder—Paclitaxel—kidney cancer	0.000412	0.002	CcSEcCtD
Tetrabenazine—Decreased appetite—Dactinomycin—kidney cancer	0.000409	0.00198	CcSEcCtD
Tetrabenazine—Diarrhoea—Vinblastine—kidney cancer	0.000409	0.00198	CcSEcCtD
Tetrabenazine—Body temperature increased—Sorafenib—kidney cancer	0.000408	0.00198	CcSEcCtD
Tetrabenazine—Diarrhoea—Everolimus—kidney cancer	0.000407	0.00197	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Vincristine—kidney cancer	0.000406	0.00197	CcSEcCtD
Tetrabenazine—Fatigue—Dactinomycin—kidney cancer	0.000406	0.00197	CcSEcCtD
Tetrabenazine—Tension—Paclitaxel—kidney cancer	0.000401	0.00195	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GSTM1—kidney cancer	0.000398	0.0129	CbGpPWpGaD
Tetrabenazine—Nervousness—Paclitaxel—kidney cancer	0.000397	0.00193	CcSEcCtD
Tetrabenazine—Dizziness—Vinblastine—kidney cancer	0.000395	0.00192	CcSEcCtD
Tetrabenazine—Dizziness—Everolimus—kidney cancer	0.000393	0.00191	CcSEcCtD
Tetrabenazine—Body temperature increased—Sunitinib—kidney cancer	0.000393	0.0019	CcSEcCtD
Tetrabenazine—Diarrhoea—Erlotinib—kidney cancer	0.000393	0.0019	CcSEcCtD
Tetrabenazine—Hypotension—Vincristine—kidney cancer	0.000393	0.0019	CcSEcCtD
Tetrabenazine—Bradycardia—Capecitabine—kidney cancer	0.000393	0.0019	CcSEcCtD
Tetrabenazine—Nervous system disorder—Gemcitabine—kidney cancer	0.000391	0.0019	CcSEcCtD
Tetrabenazine—Feeling abnormal—Dactinomycin—kidney cancer	0.000388	0.00188	CcSEcCtD
Tetrabenazine—Skin disorder—Gemcitabine—kidney cancer	0.000387	0.00188	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000386	0.00187	CcSEcCtD
Tetrabenazine—Tremor—Paclitaxel—kidney cancer	0.000383	0.00186	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Capecitabine—kidney cancer	0.000381	0.00185	CcSEcCtD
Tetrabenazine—Insomnia—Vincristine—kidney cancer	0.00038	0.00184	CcSEcCtD
Tetrabenazine—Vomiting—Vinblastine—kidney cancer	0.00038	0.00184	CcSEcCtD
Tetrabenazine—Dizziness—Erlotinib—kidney cancer	0.00038	0.00184	CcSEcCtD
Tetrabenazine—Vomiting—Everolimus—kidney cancer	0.000378	0.00183	CcSEcCtD
Tetrabenazine—Urethral disorder—Capecitabine—kidney cancer	0.000378	0.00183	CcSEcCtD
Tetrabenazine—Agitation—Paclitaxel—kidney cancer	0.000376	0.00182	CcSEcCtD
Tetrabenazine—Headache—Vinblastine—kidney cancer	0.000374	0.00181	CcSEcCtD
Tetrabenazine—Headache—Everolimus—kidney cancer	0.000373	0.00181	CcSEcCtD
Tetrabenazine—Hypotension—Gemcitabine—kidney cancer	0.000373	0.00181	CcSEcCtD
Tetrabenazine—Body temperature increased—Dactinomycin—kidney cancer	0.000372	0.0018	CcSEcCtD
Tetrabenazine—Asthenia—Sorafenib—kidney cancer	0.000371	0.0018	CcSEcCtD
Tetrabenazine—Leukopenia—Paclitaxel—kidney cancer	0.000366	0.00178	CcSEcCtD
Tetrabenazine—Decreased appetite—Vincristine—kidney cancer	0.000365	0.00177	CcSEcCtD
Tetrabenazine—Vomiting—Erlotinib—kidney cancer	0.000365	0.00177	CcSEcCtD
Tetrabenazine—Fatigue—Vincristine—kidney cancer	0.000362	0.00176	CcSEcCtD
Tetrabenazine—Insomnia—Gemcitabine—kidney cancer	0.000361	0.00175	CcSEcCtD
Tetrabenazine—Eye disorder—Capecitabine—kidney cancer	0.00036	0.00175	CcSEcCtD
Tetrabenazine—Headache—Erlotinib—kidney cancer	0.00036	0.00174	CcSEcCtD
Tetrabenazine—Constipation—Vincristine—kidney cancer	0.000359	0.00174	CcSEcCtD
Tetrabenazine—Osteoarthritis—Doxorubicin—kidney cancer	0.000359	0.00174	CcSEcCtD
Tetrabenazine—Cardiac disorder—Capecitabine—kidney cancer	0.000358	0.00174	CcSEcCtD
Tetrabenazine—Asthenia—Sunitinib—kidney cancer	0.000357	0.00173	CcSEcCtD
Tetrabenazine—Dyspnoea—Gemcitabine—kidney cancer	0.000356	0.00172	CcSEcCtD
Tetrabenazine—Nausea—Vinblastine—kidney cancer	0.000355	0.00172	CcSEcCtD
Tetrabenazine—Somnolence—Gemcitabine—kidney cancer	0.000355	0.00172	CcSEcCtD
Tetrabenazine—Nausea—Everolimus—kidney cancer	0.000353	0.00171	CcSEcCtD
Tetrabenazine—Diarrhoea—Sorafenib—kidney cancer	0.000353	0.00171	CcSEcCtD
Tetrabenazine—Angiopathy—Capecitabine—kidney cancer	0.00035	0.0017	CcSEcCtD
Tetrabenazine—Anxiety—Paclitaxel—kidney cancer	0.000347	0.00168	CcSEcCtD
Tetrabenazine—Decreased appetite—Gemcitabine—kidney cancer	0.000347	0.00168	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000346	0.00168	CcSEcCtD
Tetrabenazine—Fatigue—Gemcitabine—kidney cancer	0.000344	0.00167	CcSEcCtD
Tetrabenazine—Dizziness—Sorafenib—kidney cancer	0.000342	0.00166	CcSEcCtD
Tetrabenazine—Constipation—Gemcitabine—kidney cancer	0.000341	0.00165	CcSEcCtD
Tetrabenazine—Nausea—Erlotinib—kidney cancer	0.000341	0.00165	CcSEcCtD
Tetrabenazine—Dry mouth—Paclitaxel—kidney cancer	0.000341	0.00165	CcSEcCtD
Tetrabenazine—Diarrhoea—Sunitinib—kidney cancer	0.00034	0.00165	CcSEcCtD
Tetrabenazine—Ataxia—Doxorubicin—kidney cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Mental disorder—Capecitabine—kidney cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Asthenia—Dactinomycin—kidney cancer	0.000338	0.00164	CcSEcCtD
Tetrabenazine—Confusional state—Paclitaxel—kidney cancer	0.000337	0.00163	CcSEcCtD
Tetrabenazine—Body temperature increased—Vincristine—kidney cancer	0.000332	0.00161	CcSEcCtD
Tetrabenazine—Dizziness—Sunitinib—kidney cancer	0.000329	0.00159	CcSEcCtD
Tetrabenazine—Feeling abnormal—Gemcitabine—kidney cancer	0.000329	0.00159	CcSEcCtD
Tetrabenazine—Vomiting—Sorafenib—kidney cancer	0.000328	0.00159	CcSEcCtD
Tetrabenazine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000328	0.00159	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Doxorubicin—kidney cancer	0.000328	0.00159	CcSEcCtD
Tetrabenazine—Nervous system disorder—Paclitaxel—kidney cancer	0.000327	0.00159	CcSEcCtD
Tetrabenazine—Breast disorder—Doxorubicin—kidney cancer	0.000325	0.00157	CcSEcCtD
Tetrabenazine—Skin disorder—Paclitaxel—kidney cancer	0.000324	0.00157	CcSEcCtD
Tetrabenazine—Headache—Sorafenib—kidney cancer	0.000324	0.00157	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000323	0.00156	CcSEcCtD
Tetrabenazine—Diarrhoea—Dactinomycin—kidney cancer	0.000322	0.00156	CcSEcCtD
Tetrabenazine—Vomiting—Sunitinib—kidney cancer	0.000316	0.00153	CcSEcCtD
Tetrabenazine—Body temperature increased—Gemcitabine—kidney cancer	0.000315	0.00153	CcSEcCtD
Tetrabenazine—Tremor—Capecitabine—kidney cancer	0.000315	0.00153	CcSEcCtD
Tetrabenazine—Hypotension—Paclitaxel—kidney cancer	0.000312	0.00151	CcSEcCtD
Tetrabenazine—Headache—Sunitinib—kidney cancer	0.000311	0.00151	CcSEcCtD
Tetrabenazine—Dysphagia—Doxorubicin—kidney cancer	0.000311	0.00151	CcSEcCtD
Tetrabenazine—Nausea—Sorafenib—kidney cancer	0.000307	0.00149	CcSEcCtD
Tetrabenazine—Insomnia—Paclitaxel—kidney cancer	0.000302	0.00146	CcSEcCtD
Tetrabenazine—Asthenia—Vincristine—kidney cancer	0.000302	0.00146	CcSEcCtD
Tetrabenazine—Leukopenia—Capecitabine—kidney cancer	0.000301	0.00146	CcSEcCtD
Tetrabenazine—Vomiting—Dactinomycin—kidney cancer	0.000299	0.00145	CcSEcCtD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.000299	0.00968	CbGpPWpGaD
Tetrabenazine—Bronchitis—Doxorubicin—kidney cancer	0.000299	0.00145	CcSEcCtD
Tetrabenazine—Dyspnoea—Paclitaxel—kidney cancer	0.000298	0.00144	CcSEcCtD
Tetrabenazine—Somnolence—Paclitaxel—kidney cancer	0.000297	0.00144	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—ACHE—kidney cancer	0.000296	0.00957	CbGpPWpGaD
Tetrabenazine—Nausea—Sunitinib—kidney cancer	0.000295	0.00143	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ACY1—kidney cancer	0.000291	0.00942	CbGpPWpGaD
Tetrabenazine—Dysuria—Doxorubicin—kidney cancer	0.00029	0.00141	CcSEcCtD
Tetrabenazine—Decreased appetite—Paclitaxel—kidney cancer	0.00029	0.00141	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000289	0.0014	CcSEcCtD
Tetrabenazine—Fatigue—Paclitaxel—kidney cancer	0.000288	0.0014	CcSEcCtD
Tetrabenazine—Diarrhoea—Vincristine—kidney cancer	0.000288	0.00139	CcSEcCtD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000287	0.0093	CbGpPWpGaD
Tetrabenazine—Asthenia—Gemcitabine—kidney cancer	0.000286	0.00139	CcSEcCtD
Tetrabenazine—Constipation—Paclitaxel—kidney cancer	0.000286	0.00138	CcSEcCtD
Tetrabenazine—Anxiety—Capecitabine—kidney cancer	0.000285	0.00138	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000284	0.00138	CcSEcCtD
Tetrabenazine—Dry mouth—Capecitabine—kidney cancer	0.00028	0.00136	CcSEcCtD
Tetrabenazine—Nausea—Dactinomycin—kidney cancer	0.000279	0.00135	CcSEcCtD
Tetrabenazine—Dizziness—Vincristine—kidney cancer	0.000278	0.00135	CcSEcCtD
Tetrabenazine—Drowsiness—Doxorubicin—kidney cancer	0.000277	0.00134	CcSEcCtD
Tetrabenazine—Confusional state—Capecitabine—kidney cancer	0.000276	0.00134	CcSEcCtD
Tetrabenazine—Feeling abnormal—Paclitaxel—kidney cancer	0.000275	0.00133	CcSEcCtD
Tetrabenazine—Diarrhoea—Gemcitabine—kidney cancer	0.000273	0.00132	CcSEcCtD
Tetrabenazine—Nervous system disorder—Capecitabine—kidney cancer	0.000269	0.0013	CcSEcCtD
Tetrabenazine—CYP2D6—renal system—kidney cancer	0.000268	0.0381	CbGeAlD
Tetrabenazine—Vomiting—Vincristine—kidney cancer	0.000267	0.0013	CcSEcCtD
Tetrabenazine—Skin disorder—Capecitabine—kidney cancer	0.000266	0.00129	CcSEcCtD
Tetrabenazine—Sweating—Doxorubicin—kidney cancer	0.000265	0.00129	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Capecitabine—kidney cancer	0.000265	0.00128	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000264	0.00856	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Paclitaxel—kidney cancer	0.000264	0.00128	CcSEcCtD
Tetrabenazine—Headache—Vincristine—kidney cancer	0.000263	0.00128	CcSEcCtD
Tetrabenazine—CYP2D6—kidney—kidney cancer	0.000259	0.0368	CbGeAlD
Tetrabenazine—Hypotension—Capecitabine—kidney cancer	0.000256	0.00124	CcSEcCtD
Tetrabenazine—Vomiting—Gemcitabine—kidney cancer	0.000254	0.00123	CcSEcCtD
Tetrabenazine—Bradycardia—Doxorubicin—kidney cancer	0.000253	0.00123	CcSEcCtD
Tetrabenazine—Headache—Gemcitabine—kidney cancer	0.00025	0.00121	CcSEcCtD
Tetrabenazine—Nausea—Vincristine—kidney cancer	0.00025	0.00121	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000248	0.00803	CbGpPWpGaD
Tetrabenazine—Insomnia—Capecitabine—kidney cancer	0.000248	0.0012	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—PDHB—kidney cancer	0.000247	0.00801	CbGpPWpGaD
Tetrabenazine—Urinary tract disorder—Doxorubicin—kidney cancer	0.000246	0.00119	CcSEcCtD
Tetrabenazine—Dyspnoea—Capecitabine—kidney cancer	0.000244	0.00118	CcSEcCtD
Tetrabenazine—Urethral disorder—Doxorubicin—kidney cancer	0.000244	0.00118	CcSEcCtD
Tetrabenazine—CYP2D6—Xenobiotics—CYP1A1—kidney cancer	0.00024	0.00778	CbGpPWpGaD
Tetrabenazine—Asthenia—Paclitaxel—kidney cancer	0.00024	0.00116	CcSEcCtD
Tetrabenazine—Decreased appetite—Capecitabine—kidney cancer	0.000238	0.00115	CcSEcCtD
Tetrabenazine—Nausea—Gemcitabine—kidney cancer	0.000237	0.00115	CcSEcCtD
Tetrabenazine—Fatigue—Capecitabine—kidney cancer	0.000236	0.00115	CcSEcCtD
Tetrabenazine—Constipation—Capecitabine—kidney cancer	0.000234	0.00114	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—KCNMA1—kidney cancer	0.000234	0.00758	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CCBL1—kidney cancer	0.000233	0.00753	CbGpPWpGaD
Tetrabenazine—Eye disorder—Doxorubicin—kidney cancer	0.000232	0.00113	CcSEcCtD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000231	0.00748	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Doxorubicin—kidney cancer	0.000231	0.00112	CcSEcCtD
Tetrabenazine—Diarrhoea—Paclitaxel—kidney cancer	0.000228	0.00111	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000228	0.00738	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000226	0.00732	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Capecitabine—kidney cancer	0.000226	0.00109	CcSEcCtD
Tetrabenazine—Angiopathy—Doxorubicin—kidney cancer	0.000226	0.00109	CcSEcCtD
Tetrabenazine—CYP2D6—Biological oxidations—ACY1—kidney cancer	0.000221	0.00716	CbGpPWpGaD
Tetrabenazine—Dizziness—Paclitaxel—kidney cancer	0.000221	0.00107	CcSEcCtD
Tetrabenazine—Mental disorder—Doxorubicin—kidney cancer	0.000218	0.00106	CcSEcCtD
Tetrabenazine—Body temperature increased—Capecitabine—kidney cancer	0.000217	0.00105	CcSEcCtD
Tetrabenazine—Tension—Doxorubicin—kidney cancer	0.000212	0.00103	CcSEcCtD
Tetrabenazine—Vomiting—Paclitaxel—kidney cancer	0.000212	0.00103	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.00021	0.00681	CbGpPWpGaD
Tetrabenazine—Nervousness—Doxorubicin—kidney cancer	0.00021	0.00102	CcSEcCtD
Tetrabenazine—Headache—Paclitaxel—kidney cancer	0.000209	0.00101	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—PPAT—kidney cancer	0.000202	0.00653	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GLIPR1—kidney cancer	0.000202	0.00653	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000199	0.00644	CbGpPWpGaD
Tetrabenazine—Agitation—Doxorubicin—kidney cancer	0.000199	0.000964	CcSEcCtD
Tetrabenazine—Nausea—Paclitaxel—kidney cancer	0.000198	0.000962	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.000197	0.00638	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000197	0.00637	CbGpPWpGaD
Tetrabenazine—Asthenia—Capecitabine—kidney cancer	0.000197	0.000953	CcSEcCtD
Tetrabenazine—Leukopenia—Doxorubicin—kidney cancer	0.000194	0.000939	CcSEcCtD
Tetrabenazine—Diarrhoea—Capecitabine—kidney cancer	0.000187	0.000909	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—FH—kidney cancer	0.000187	0.00607	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APRT—kidney cancer	0.000187	0.00607	CbGpPWpGaD
Tetrabenazine—Anxiety—Doxorubicin—kidney cancer	0.000184	0.00089	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000183	0.00593	CbGpPWpGaD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000183	0.000887	CcSEcCtD
Tetrabenazine—Dizziness—Capecitabine—kidney cancer	0.000181	0.000878	CcSEcCtD
Tetrabenazine—Dry mouth—Doxorubicin—kidney cancer	0.00018	0.000874	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.000179	0.00578	CbGpPWpGaD
Tetrabenazine—Confusional state—Doxorubicin—kidney cancer	0.000178	0.000863	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GPC3—kidney cancer	0.000176	0.0057	CbGpPWpGaD
Tetrabenazine—Vomiting—Capecitabine—kidney cancer	0.000174	0.000845	CcSEcCtD
Tetrabenazine—Nervous system disorder—Doxorubicin—kidney cancer	0.000173	0.00084	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—ACHE—kidney cancer	0.000173	0.00561	CbGpPWpGaD
Tetrabenazine—Headache—Capecitabine—kidney cancer	0.000172	0.000832	CcSEcCtD
Tetrabenazine—Skin disorder—Doxorubicin—kidney cancer	0.000172	0.000832	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CA2—kidney cancer	0.000171	0.00555	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000171	0.000828	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ALAD—kidney cancer	0.000167	0.00541	CbGpPWpGaD
Tetrabenazine—Hypotension—Doxorubicin—kidney cancer	0.000165	0.0008	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ST3GAL2—kidney cancer	0.000163	0.00528	CbGpPWpGaD
Tetrabenazine—Nausea—Capecitabine—kidney cancer	0.000163	0.000789	CcSEcCtD
Tetrabenazine—Insomnia—Doxorubicin—kidney cancer	0.00016	0.000774	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ALDH1A1—kidney cancer	0.000159	0.00516	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000158	0.0051	CbGpPWpGaD
Tetrabenazine—Dyspnoea—Doxorubicin—kidney cancer	0.000157	0.000763	CcSEcCtD
Tetrabenazine—Somnolence—Doxorubicin—kidney cancer	0.000157	0.000761	CcSEcCtD
Tetrabenazine—Decreased appetite—Doxorubicin—kidney cancer	0.000154	0.000744	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—SLC5A3—kidney cancer	0.000153	0.00495	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PGK1—kidney cancer	0.000153	0.00495	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000152	0.00493	CbGpPWpGaD
Tetrabenazine—Fatigue—Doxorubicin—kidney cancer	0.000152	0.000738	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000152	0.00492	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000152	0.00492	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000152	0.00492	CbGpPWpGaD
Tetrabenazine—Constipation—Doxorubicin—kidney cancer	0.000151	0.000732	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—BCHE—kidney cancer	0.000151	0.00488	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—LDHB—kidney cancer	0.00015	0.00485	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—HNF1B—kidney cancer	0.000149	0.00484	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—KCNMA1—kidney cancer	0.000146	0.00472	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Doxorubicin—kidney cancer	0.000146	0.000706	CcSEcCtD
Tetrabenazine—Body temperature increased—Doxorubicin—kidney cancer	0.00014	0.000677	CcSEcCtD
Tetrabenazine—DRD2—Circadian rythm related genes—JUND—kidney cancer	0.000131	0.00423	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CA9—kidney cancer	0.00013	0.00421	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	0.000127	0.00411	CbGpPWpGaD
Tetrabenazine—Asthenia—Doxorubicin—kidney cancer	0.000127	0.000614	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000126	0.00407	CbGpPWpGaD
Tetrabenazine—DRD2—Hypothetical Network for Drug Addiction—MAPK3—kidney cancer	0.000125	0.00406	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—ALDH1A1—kidney cancer	0.000121	0.00392	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Doxorubicin—kidney cancer	0.000121	0.000586	CcSEcCtD
Tetrabenazine—DRD2—Hypothetical Network for Drug Addiction—MAPK1—kidney cancer	0.000119	0.00386	CbGpPWpGaD
Tetrabenazine—Dizziness—Doxorubicin—kidney cancer	0.000117	0.000566	CcSEcCtD
Tetrabenazine—Vomiting—Doxorubicin—kidney cancer	0.000112	0.000544	CcSEcCtD
Tetrabenazine—Headache—Doxorubicin—kidney cancer	0.000111	0.000536	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CRABP1—kidney cancer	0.00011	0.00358	CbGpPWpGaD
Tetrabenazine—Nausea—Doxorubicin—kidney cancer	0.000105	0.000509	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—ITPR2—kidney cancer	0.000103	0.00332	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—OR4C13—kidney cancer	0.000101	0.00327	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—BRAF—kidney cancer	0.0001	0.00325	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	9.98e-05	0.00323	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	9.85e-05	0.00319	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.47e-05	0.00306	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTT1—kidney cancer	9.37e-05	0.00303	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ACHE—kidney cancer	9.37e-05	0.00303	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—OR4C13—kidney cancer	9.18e-05	0.00297	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SCARB1—kidney cancer	8.87e-05	0.00287	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS1—kidney cancer	8.78e-05	0.00284	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—ANXA1—kidney cancer	8.74e-05	0.00283	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PSMD7—kidney cancer	8.61e-05	0.00279	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—RAF1—kidney cancer	8.39e-05	0.00272	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—EGR1—kidney cancer	8.32e-05	0.00269	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—BCHE—kidney cancer	8.16e-05	0.00264	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	8.09e-05	0.00262	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SLC5A5—kidney cancer	8.06e-05	0.00261	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	8.01e-05	0.00259	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—SLC2A1—kidney cancer	7.78e-05	0.00252	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	7.74e-05	0.0025	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—BRAF—kidney cancer	7.7e-05	0.00249	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.55e-05	0.00244	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.44e-05	0.00241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	7.12e-05	0.0023	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	6.95e-05	0.00225	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	6.67e-05	0.00216	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.59e-05	0.00213	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTP1—kidney cancer	6.49e-05	0.0021	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—RAF1—kidney cancer	6.43e-05	0.00208	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ABCB1—kidney cancer	6.15e-05	0.00199	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	6.11e-05	0.00198	CbGpPWpGaD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.03e-05	0.00195	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—kidney cancer	5.97e-05	0.00193	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—MAPK1—kidney cancer	5.75e-05	0.00186	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP1A1—kidney cancer	5.66e-05	0.00183	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—OR4C13—kidney cancer	5.42e-05	0.00175	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ANXA1—kidney cancer	5.29e-05	0.00171	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.94e-05	0.0016	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.87e-05	0.00158	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.65e-05	0.0015	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LATS1—kidney cancer	4.61e-05	0.00149	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	4.54e-05	0.00147	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	4.47e-05	0.00145	CbGpPWpGaD
Tetrabenazine—SLC18A2—Neuronal System—MAPK1—kidney cancer	4.41e-05	0.00143	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	4.3e-05	0.00139	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—POMC—kidney cancer	4.28e-05	0.00139	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	4.24e-05	0.00137	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—POMC—kidney cancer	4.22e-05	0.00136	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—AKAP13—kidney cancer	4.2e-05	0.00136	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AMER1—kidney cancer	3.92e-05	0.00127	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—AKAP13—kidney cancer	3.81e-05	0.00123	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACY1—kidney cancer	3.78e-05	0.00122	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ITPR2—kidney cancer	3.57e-05	0.00115	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—JUN—kidney cancer	3.49e-05	0.00113	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—RAF1—kidney cancer	3.46e-05	0.00112	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	3.4e-05	0.0011	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—PTEN—kidney cancer	3.37e-05	0.00109	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTGS2—kidney cancer	3.36e-05	0.00109	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GPC3—kidney cancer	3.28e-05	0.00106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CER1—kidney cancer	3.28e-05	0.00106	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ITPR2—kidney cancer	3.24e-05	0.00105	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PDHB—kidney cancer	3.22e-05	0.00104	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—POMC—kidney cancer	3.21e-05	0.00104	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CCBL1—kidney cancer	3.02e-05	0.000979	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ANXA1—kidney cancer	2.99e-05	0.000968	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PTEN—kidney cancer	2.93e-05	0.000949	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SFRP2—kidney cancer	2.79e-05	0.000904	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ANXA1—kidney cancer	2.72e-05	0.000879	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.62e-05	0.000848	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PPAT—kidney cancer	2.62e-05	0.000848	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—POMC—kidney cancer	2.59e-05	0.000839	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APRT—kidney cancer	2.44e-05	0.000789	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—FH—kidney cancer	2.44e-05	0.000789	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—kidney cancer	2.3e-05	0.000745	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GPC3—kidney cancer	2.29e-05	0.000742	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—AKAP13—kidney cancer	2.25e-05	0.000729	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CASP2—kidney cancer	2.25e-05	0.000729	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CA2—kidney cancer	2.23e-05	0.000721	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALAD—kidney cancer	2.17e-05	0.000703	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	2.12e-05	0.000686	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	2.07e-05	0.000671	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—PIK3CA—kidney cancer	2.07e-05	0.00067	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—GRB7—kidney cancer	2.06e-05	0.000666	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PGK1—kidney cancer	1.99e-05	0.000643	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.99e-05	0.000643	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—LDHB—kidney cancer	1.95e-05	0.000631	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ITPR2—kidney cancer	1.91e-05	0.00062	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNA1—kidney cancer	1.74e-05	0.000562	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EIF4EBP1—kidney cancer	1.73e-05	0.000558	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HSPB1—kidney cancer	1.73e-05	0.000558	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CA9—kidney cancer	1.69e-05	0.000547	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TSC1—kidney cancer	1.6e-05	0.000519	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PSMD7—kidney cancer	1.6e-05	0.000519	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ANXA1—kidney cancer	1.6e-05	0.000519	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FLT1—kidney cancer	1.55e-05	0.000503	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—POMC—kidney cancer	1.46e-05	0.000474	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUNB—kidney cancer	1.44e-05	0.000466	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PAK1—kidney cancer	1.44e-05	0.000466	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.44e-05	0.000465	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.34e-05	0.000432	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—POMC—kidney cancer	1.33e-05	0.000431	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.22e-05	0.000394	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ACHE—kidney cancer	1.22e-05	0.000394	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF2—kidney cancer	1.18e-05	0.000381	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN2B—kidney cancer	1.17e-05	0.000379	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SCARB1—kidney cancer	1.15e-05	0.000373	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS1—kidney cancer	1.14e-05	0.000369	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IGF1R—kidney cancer	1.14e-05	0.000368	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PSMD7—kidney cancer	1.12e-05	0.000362	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—RAF1—kidney cancer	1.1e-05	0.000355	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—IL2—kidney cancer	1.08e-05	0.000351	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—BCHE—kidney cancer	1.06e-05	0.000343	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC5A5—kidney cancer	1.05e-05	0.000339	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—SLC2A1—kidney cancer	1.01e-05	0.000328	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL2—kidney cancer	9.83e-06	0.000318	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HIF1A—kidney cancer	9.37e-06	0.000303	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TSC2—kidney cancer	9.35e-06	0.000303	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KDR—kidney cancer	8.96e-06	0.00029	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—kidney cancer	8.44e-06	0.000273	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—APC—kidney cancer	8.26e-06	0.000267	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KIT—kidney cancer	8.26e-06	0.000267	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ABCB1—kidney cancer	7.99e-06	0.000259	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAPK3—kidney cancer	7.91e-06	0.000256	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—POMC—kidney cancer	7.86e-06	0.000254	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—BRAF—kidney cancer	7.76e-06	0.000251	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—kidney cancer	7.76e-06	0.000251	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—MAPK1—kidney cancer	7.52e-06	0.000244	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—kidney cancer	7.35e-06	0.000238	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PIK3CA—kidney cancer	7.19e-06	0.000233	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—KRAS—kidney cancer	7.11e-06	0.00023	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PIK3CA—kidney cancer	6.53e-06	0.000211	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAF1—kidney cancer	6.48e-06	0.00021	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RELA—kidney cancer	6.45e-06	0.000209	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB2—kidney cancer	6.41e-06	0.000207	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MTOR—kidney cancer	6.33e-06	0.000205	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CDKN1B—kidney cancer	5.94e-06	0.000192	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL2—kidney cancer	5.81e-06	0.000188	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CCND1—kidney cancer	5.66e-06	0.000183	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—JUN—kidney cancer	5.65e-06	0.000183	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CTNNB1—kidney cancer	5.61e-06	0.000182	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—POMC—kidney cancer	5.48e-06	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PTEN—kidney cancer	5.47e-06	0.000177	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—kidney cancer	4.94e-06	0.00016	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK3—kidney cancer	4.67e-06	0.000151	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MYC—kidney cancer	4.54e-06	0.000147	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MAPK1—kidney cancer	4.44e-06	0.000144	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTGS2—kidney cancer	4.37e-06	0.000142	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KRAS—kidney cancer	4.2e-06	0.000136	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PIK3CA—kidney cancer	3.86e-06	0.000125	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PTEN—kidney cancer	3.81e-06	0.000123	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—kidney cancer	3.73e-06	0.000121	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.69e-06	8.71e-05	CbGpPWpGaD
